Furthermore, as patients with the worst clinical outcome showed higher expression of VEGFR-1 or coexpression of VEGFR-1 and MMP9 in the tumor than in peritumoral tissues, VEGFR-1 has been proposed as a prognostic marker for hepatocellular carcinoma [116,117,118]. The gene discussed is FLT1; the disease is neoplasm.